PurpleLab, using its healthcare claims database and HealthNexus analytics platform, analyzed medical and pharmacy claims for 12.2M people taking GLP-1 medications from January 2019 May 2024
Historically, hospitals have filled this gap with newer, complex procedures like CAR-T therapy
In comparison, GLP-1 induced a 22% decrease in body fat mass and a 4% reduction in lean mass
Whether you are considering retatrutide, already on it, or switching from another GLP-1 medication , this is the reference you will want bookmarked
What is the connection between Tylenol/Acetaminophen/Paracetamol with Autism
Table 1 shows the content of the TAGs, containing MCFAs (8:0-14:0) in human milk collected in four countries, summarized from eight publications (4, 24, 3136)